Neurology & Neuroscience Center of Ohio

Toledo, Ohio 43623

0 studies enrolling now · 18 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Depression, Diabetic Neuropathy, Diabetic Peripheral Neuropathic Pain, Major Depressive Disorder, Mild Cognitive Impairment, So Stated, Neuropathic Pain, Pain, Peripheral Neuropathy, Smoking Cessation

Studies at this site

• SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study — Stopped early
• SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder — Completed
• Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD) — Completed
• Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD) — Stopped early
• ELND005 in Patients With Mild to Moderate Alzheimer's Disease — Completed
• ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease — Completed
• Smoking Cessation Study In Healthy Adolescent Smokers — Completed
• Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy — Completed
• Study of the Safety, Tolerability and Efficacy of V3381 in Patients With Diabetic Peripheral Neuropathic Pain — Completed
• Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients — Stopped early
• Diabetic Peripheral Neuropathic Pain (DPNP) — Completed
• Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression — Stopped early
• A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease — Completed
• A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease — Stopped early
• Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression — Completed
• Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy — Completed
• Safety, Tolerability and Efficacy Study to Evaluate Subjects With Mild Cognitive Impairment — Completed
• Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder — Completed